Allarity Therapeutics Inc ALLR

$0.90 +0.06 (7.48%)

Valuation

Market cap
14,240,000
Revenue TTM
$320,000
Net income TTM
$-11,230,000
PE ratio
0.00
Forward PE
—
Profit margin
-3,509.37%
Debt to equity
0.21

Trading

Volume
232,000
Avg volume
112,942
Day's range
$0.82 – $0.92
Shares out
15,911,000
Stochastic %K
40%
Beta
0.57
Analysts
Sell
Price target
$11.00

Price

Company profile

Allarity Therapeutics, Inc., a clinical-stage precision medicine pharmaceutical company, focuses on developing anti-cancer therapeutics for patients with unmet medical needs in Denmark and the United States. The company develops drugs for the personalized treatment of cancer using drug-specific companion diagnostics generated by its proprietary drug response predictor (DRP) technology. Its lead drug candidate is sten...

Show more

Allarity Therapeutics, Inc., a clinical-stage precision medicine pharmaceutical company, focuses on developing anti-cancer therapeutics for patients with unmet medical needs in Denmark and the United States. The company develops drugs for the personalized treatment of cancer using drug-specific companion diagnostics generated by its proprietary drug response predictor (DRP) technology. Its lead drug candidate is stenoparib, a dual inhibitor of poly-ADP-ribose polymerase (PARP1/2), which is in a Phase 2 clinical trial for patients with advanced and recurrent ovarian cancer. It is also developing stenoparib with temozolomide, a PARP and WNT inhibitor in combination with a DNA-alkylating chemotherapy agent, which is in a Phase 2 clinical trial for patients with relapsed small cell lung cancer; and stenoparib-DRP, a companion diagnostic product used to select patients for stenoparib treatment. Allarity Therapeutics, Inc. is headquartered in Tarpon Springs, Florida.

Industry
Biotechnology
Sector
Healthcare
Phone
401 426 4664
Website
https://www.allarity.com
Address
123 E. Tarpon Ave., Tarpon Springs, United States

Latest news

Stocktwits

MarginMonster Oct 18, 4:41 PM
$ALLR I’m keeping an eye on this with a hopeful heart.
0 replies
Georgia80 Oct 17, 6:24 PM
$ALLR Potentially meaningful cancer-drug catalyst\\
0 replies
topstockalerts Oct 16, 8:44 PM
$ALLR this one is quietly making believers
1 replies
ItUsuallyIs Oct 16, 3:45 PM
$ALLR
0 replies
JuggernautRaider Oct 15, 9:08 PM
$TNXP according to Tony from New York aka @Duediligence20 that don’t matter ⚾️ $ALLR $ALT $AXSM 🧠 😋 🍱 🇺🇸 🇮🇹
1 replies
gscdefense Oct 15, 7:56 PM
$ALLR Is the buyback still in effect? I walked away from this 2 years ago with some nasty losses. Jensen sucks ass but the stock has real potential. Does anyone track daily O/S to see generally where the buyback program is at?
0 replies
JuggernautRaider Oct 15, 7:15 PM
$ALLR woah what happened 💊 $TLSA 💨 $ALT 💉 just run you fat $NVO nordisk kats 🇺🇸 💥 🇩🇰
0 replies
RAKIN13 Oct 15, 6:23 PM
$ALLR just want to break even. This ceo is a fucking liar. Inflection year my ass. He’s fucked up everything. His lack of focus has caused this all because of a stupid SPAC. This is such a shit show I’m done
0 replies